Serveur d'exploration Covid (26 mars) - Analysis (new)

Index « Auteurs » - entrée « Erik De Clercq »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Eric Yim < Erik De Clercq < Erik Ingelsson  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000094 (2020) Guangdi Li ; Erik De ClercqTherapeutic options for the 2019 novel coronavirus (2019-nCoV).
000744 (2013) Kiran Gangarapu [Inde] ; Sarangapani Manda ; Anvesh Jallapally ; Sreekanth Thota [États-Unis] ; Subhas S. Karki ; Jan Balzarini [Belgique] ; Erik De Clercq [Belgique] ; Harukuni Tokuda [Japon]Synthesis of thiocarbohydrazide and carbohydrazide derivatives as possible biologically active agents
000751 (2012) Subhas S. Karki [Inde] ; Amol A. Kulkarni [Inde] ; Sujeet Kumar [Inde] ; Suresh Kumar Veliyath [Inde] ; Erik De Clercq [Belgique] ; Jan Balzarini [Belgique]Synthesis and biological evaluation of 2-(5-substituted-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)- N -substituted-hydrazinecarbothioamides
000752 (2012) Pradeep Kumar [Inde] ; Balasubramanian Narasimhan [Inde] ; Kalavathy Ramasamy [Malaisie] ; Vasudevan Mani [Malaisie] ; Rakesh Kumar Mishra [Malaisie] ; Abu Bakar Abdul Majeed [Malaisie] ; Erik De Clercq [Belgique]N ′-[4-[(Substituted imino)methyl]benzylidene]-substituted benzohydrazides: synthesis, antimicrobial, antiviral, and anticancer evaluation, and QSAR studies

List of associated KwdEn.i

Nombre de
documents
Descripteur
12,3-Dioxo-2,3-dihydroindole
1Adenosine Monophosphate (analogs & derivatives)
1Adenosine Monophosphate (therapeutic use)
1Alanine (analogs & derivatives)
1Alanine (therapeutic use)
1Anticancer
1Antimicrobial
1Antimicrobial activity
1Antiviral
1Antiviral Agents (therapeutic use)
1Antiviral activity
1Betacoronavirus (drug effects)
1Betacoronavirus (genetics)
1Betacoronavirus (pathogenicity)
1Coronavirus Infections (drug therapy)
1Cytotoxicity assay
1Drug Repositioning
1HIV Infections (drug therapy)
1Hepatitis B (drug therapy)
1Hepatitis C (drug therapy)
1Humans
1Hydrazides
1Influenza, Human (drug therapy)
1Interferon-alpha (pharmacology)
1Interferon-alpha (therapeutic use)
1Middle East Respiratory Syndrome Coronavirus (drug effects)
1Middle East Respiratory Syndrome Coronavirus (genetics)
1Middle East Respiratory Syndrome Coronavirus (pathogenicity)
1Nucleosides (pharmacology)
1Nucleosides (therapeutic use)
1Pneumonia, Viral (drug therapy)
1Polyethylene Glycols (pharmacology)
1Polyethylene Glycols (therapeutic use)
1Protease Inhibitors (pharmacology)
1Protease Inhibitors (therapeutic use)
1QSAR
1Recombinant Proteins (pharmacology)
1Recombinant Proteins (therapeutic use)
1SARS Virus (drug effects)
1SARS Virus (genetics)
1SARS Virus (pathogenicity)
1Spike Glycoprotein, Coronavirus (drug effects)
1Thiosemicarbazones

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/new/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/Author.i -k "Erik De Clercq" 
HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/Author.i  \
                -Sk "Erik De Clercq" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/new/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    new
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Erik De Clercq
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021